SCHEMBL21479952

SCHEMBL21479952

Cc1c(C)c(C)c(N(C)c2ccc(-c3ccccc3)cc2)c(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.41
CHKA P35790 3/20 0.39
ALDH1A1 P00352 3/20 0.38
GSK3B P49841 1/20 0.36
USP2 O75604 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PDE5A O76074 1/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
MMP13 P45452 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21479953 0.87 MEN1 (0.41) CHKAALDH1A1GSK3BPDE5AMAPK1
SCHEMBL6723783 0.82 ALDH1A1 (0.50) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL6723957 0.82 ALDH1A1 (0.50) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL6723671 0.82 ALDH1A1 (0.50) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL12249883 0.82 ALDH1A1 (0.50) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL21479951 0.80 PSMB5 (0.41) TAAR1CHKAALDH1A1GSK3BMEN1
SCHEMBL6723658 0.80 CHKA (0.53) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL2742925 0.80 CHKA (0.53) TAAR1CHKAALDH1A1GSK3BUSP2
SCHEMBL12249808 0.78 ALDH1A1 (0.48) TAAR1CHKAALDH1A1KDM4EMEN1
SCHEMBL20210148 0.78 ALDH1A1 (0.52) ALDH1A1MAPK1HSD17B10LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2023-02-21 US disclosed
EP-3544984-B1 BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2020-12-23 EP disclosed
US-20190315764-A1 BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315764-A1 BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) OCIAD1, OCIAD2, AOC1 TAAR1 420/4885CHKA 3226/4885ALDH1A1 99/4885
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD1, OCIAD2, AOC1 TAAR1 420/4885CHKA 3226/4885ALDH1A1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.